PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.14 - 0.14
0.08 - 0.20
5.0K / 202.5K (Avg.)
-6.75 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.52%
Revenue growth under 50% of 8480.HK's 38.66%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-72.72%
Negative gross profit growth while 8480.HK is at 7.87%. Joel Greenblatt would examine cost competitiveness or demand decline.
26.01%
Positive EBIT growth while 8480.HK is negative. John Neff might see a substantial edge in operational management.
34.66%
Positive operating income growth while 8480.HK is negative. John Neff might view this as a competitive edge in operations.
72.54%
Positive net income growth while 8480.HK is negative. John Neff might see a big relative performance advantage.
69.36%
Positive EPS growth while 8480.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
69.94%
Positive diluted EPS growth while 8480.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-9.91%
Share reduction while 8480.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.02%
Reduced diluted shares while 8480.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-38.20%
Negative 5Y CAGR while 8480.HK stands at 16.26%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-22.99%
Negative 3Y CAGR while 8480.HK stands at 25.43%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y OCF/share CAGR while 8480.HK is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-100.00%
Negative 3Y OCF/share CAGR while 8480.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
-116.28%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-366.90%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
31.24%
5Y equity/share CAGR is in line with 8480.HK's 30.61%. Walter Schloss would see parallel mid-term profitability and retention policies.
-11.27%
Negative 3Y equity/share growth while 8480.HK is at 0.60%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-45.06%
We cut SG&A while 8480.HK invests at 64.15%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.